← Back to shop
Tirzepatide 10mg
Dual GIP/GLP-1 receptor agonist
€59,9599.8% purity
Tirzepatide is a dual-agonist peptide that activates both the GIP and GLP-1 receptors. It is the active molecule that became known under the brand name Mounjaro. Each vial contains 10mg of high-purity lyophilised peptide.
Order via Stripe
Secure payment via Stripe
- Contents
- 10mg
- Purity
- 99.8%
- Form
- Lyophilised powder
- Intended use
- Research purposes
For research purposes only — not for human consumption.
Product highlights
- Dual agonist: GIP + GLP-1 receptors
- 10mg lyophilised peptide per vial
- High purity (99%+)
- The research molecule behind Mounjaro
- For laboratory and research use only
Storage & handling
Store at 2–8°C, dark and dry. Do not freeze. Refrigerate after reconstitution.
Research context
Tirzepatide is extensively described in published clinical research (including the SURPASS and SURMOUNT programmes) within metabolic research. We offer it solely as a research reference material and make no claims regarding human or animal use.
Test report
Independent test report available
- Lab
- Vanguard Laboratory
- Purity
- >99.80%
- Content
- 10.55 mg
- Lot
- TIRZ012026-10
